Welcome to our dedicated page for NATURES SUNSHINE PRODUCTS SEC filings (Ticker: NATR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on NATURES SUNSHINE PRODUCTS's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into NATURES SUNSHINE PRODUCTS's regulatory disclosures and financial reporting.
NATURES SUNSHINE PRODUCTS INC executive Bryant J. Yates reported routine tax-related share withholdings tied to restricted stock units, rather than open-market trades. On March 10 and 11, 2026, a total of 2,562 Common Shares were withheld at prices of $25.08 and $24.76 per share to cover tax obligations when prior restricted stock unit grants vested. After these tax-withholding dispositions, Yates directly holds 104,670 Common Shares, indicating he retains a substantial equity position in the company.
Natures Sunshine Products executive Nathan G. Brower reported routine share dispositions related to tax withholding on vested stock awards. On March 10, 2026, 1,363 common shares were withheld at $25.08 per share to cover taxes on restricted stock units granted on March 10, 2025. On March 11, 2026, 953 shares were similarly withheld at $24.76 per share for units granted on March 11, 2024. After these non‑market transactions, he holds 50,884 common shares directly.
Natures Sunshine Products EVP and General Counsel Nathan G. Brower reported routine equity compensation activity. He acquired 1,086 common shares through an exercise of derivative securities and then had 371 shares withheld at $25.06 per share to cover taxes on vesting.
Brower also received a grant of 7,250 restricted stock units at a reference price of $25.06. These RSUs vest in three equal annual installments through March 6, 2029. A prior performance-based RSU grant vested after the company achieved an adjusted EBITDA milestone of $48M over a rolling 12‑month period. Following these transactions, he directly holds 53,200 common shares.
NATURE'S SUNSHINE PRODUCTS (NATR) executive compensation moves: EVP & President, North America Kevin R. Herbert reported multiple equity-related transactions in common shares on March 6, 2026.
He acquired 1,239 common shares through an exercise or conversion tied to a performance-based restricted stock unit grant that vested after the company achieved an adjusted EBITDA milestone of $48M over a rolling 12‑month period. Upon meeting this target, half of the award vested, with the remaining half scheduled to vest one year after that milestone.
The company withheld 368 shares, valued using a $25.06 closing price, to cover taxes due at vesting, a non-market, tax-withholding disposition rather than an open-market sale. Herbert also received a new grant of 7,124 restricted stock units at a reference price of $25.06 per share, which will vest in three equal annual installments through March 6, 2029. Following these transactions, he directly holds 50,610 common shares.
Natures Sunshine Products EVP & Chief Financial Officer Leslie Shane Jones reported equity compensation activity in company common shares. Jones received 2,002 vested shares tied to achieving a $48M adjusted EBITDA milestone over a rolling 12-month period and had 878 shares withheld at $25.06 per share to cover taxes on vesting. Jones was also granted 11,798 restricted stock units, each representing one common share, which vest in three equal annual installments through March 6, 2029, bringing direct holdings to 121,514 common shares.
Natures Sunshine Products senior vice president and chief accounting officer Jonathan David Lanoy reported compensation-related equity activity in company common shares. He exercised derivative awards to acquire 913 shares and had 312 shares withheld at $25.06 per share to cover taxes on vesting, with no open-market sale. He also received a grant of 5,415 restricted stock units, each equal to one common share, which vest in three equal annual installments through March 6, 2029. A portion of his shares vested after the company achieved an adjusted EBITDA milestone of $48M over a rolling 12-month period, and he now directly holds 52,249 common shares.
Natures Sunshine Products EVP & President, Asia Daniel C. Norman reported compensation-related share activity. He acquired 1,541 Common Shares on March 6, 2026 through the vesting of performance-based restricted stock units tied to an adjusted EBITDA milestone of $48M over a rolling 12‑month period.
On the same date, 527 Common Shares were withheld at $25.06 per share to cover taxes due at vesting, a non-market disposition. He also received a grant of 10,088 restricted stock units, each representing one NATR share, vesting in three equal annual installments through March 6, 2029. Following these transactions, he directly holds 64,079 Common Shares, with additional equity exposure through the new RSU grant.
Natures Sunshine Products EVP & President, Europe Bryant J. Yates reported compensation-related share activity in Common Shares. On March 6, he received 7,761 restricted stock units (RSUs) at a reference price of $25.06 per share, which will vest in three equal annual installments through March 6, 2029. He also acquired 1,317 vested shares tied to achieving an adjusted EBITDA milestone of $48M over a rolling 12‑month period under a March 11, 2024 performance-based RSU grant. To cover taxes upon vesting, 450 shares were withheld at $25.06 per share, a non‑market tax-withholding disposition. After these transactions, Yates directly holds 107,232 Common Shares.
Romanzi Kenneth G. reported acquisition or exercise transactions in this Form 4 filing.
NATURES SUNSHINE PRODUCTS INC reported that Chief Executive Officer Kenneth G. Romanzi received a grant of 29,928 common-share-equivalent restricted stock units at a reference price of $25.06 per share. Following this award, he directly holds 132,809 common shares.
The RSUs were granted under his employment agreement dated October 10, 2025 and vest in three equal annual installments from the initial grant date through March 6, 2029, with each RSU representing the right to receive one NATR common share.
Fritz Erich A reported acquisition or exercise transactions in this Form 4 filing.
Natures Sunshine Products executive Fritz Erich, EVP of Global Supply Chain, received a grant of 8,180 common shares in the form of restricted stock units at a reference price of $25.06 per share. Each RSU represents one share of common stock and vests in three equal annual installments through March 6, 2029. Following this compensation grant, Erich directly holds 18,940 common shares, reflecting his ongoing equity stake in the company.